First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine

por Fuchs, JD, Frank, I, Kochar, N, Elizaga, M, Allen, M, Carter, D, Frahm, N, Kalams, SA, Mulligan, M, Sheets, R, Pensiero, M, Clarke, D, Eldridge, J
Publicado 2012

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies

por Fuchs, JD, Morgan, C, Bart, P, Kochar, N, Frahm, N, Swann, E, Gilbert, P, DeRosa, S, Graham, B, Nabel, G, Liao, H, Haynes, B, Tomaras, G
Publicado 2012